The uptake mechanism of gallium-67 into hepatocytes treated with carbon tetrachloride

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 2, 2007, Pages 224-229

  Abe, Shinya ^a   Suyama, Satoko ^a   Chiba, Seiko ^a   Nakao, Hajime ^a   Ohtake, Yosuke ^a   Ohkubo, Yasuhito ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Calcium channel; Calcium 45; Carbon tetrachloride; Gallium 67; Periportal hepatocyte; Perivenous hepatocyte

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ALANINE AMINOTRANSFERASE; CALCIUM 45; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL STIMULATING AGENT; CARBON TETRACHLORIDE; CYTOCHROME P450; GALLIUM CITRATE GA 67; ISOENZYME; RADICAL; VERAPAMIL;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG TRANSPORT; DRUG UPTAKE; ENZYME ACTIVITY; IN VITRO STUDY; LIVER CELL; LIVER INJURY; LIVER TOXICITY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT;

3-PYRIDINECARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-5-NITRO-4-(2-(TRIFLUOROMETHYL)PHENYL)-, METHYL ESTER; ALANINE TRANSAMINASE; ANIMALS; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM RADIOISOTOPES; CARBON TETRACHLORIDE; CELLS, CULTURED; COLLAGENASES; DIGITONIN; GALLIUM RADIOISOTOPES; HEPATOCYTES; MALE; RATS; RATS, WISTAR; VERAPAMIL;

EID: 33846965225     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.224     Document Type: Article

References (35)

1. Bekerman C., Hoffer P. B., Bitran J. D., Semin. Nucl. Med., 14, 296-323 (1984).
2. Halpern S. H. P., "Gallium-67 Citrate Imaging in Neoplastic and Inflammatory Disease," Raven Press, New York, 1980.
3. King S. C., Reiman R. J., Prosnitz L. R., J. Clin. Oncol., 12, 306-311 (1994).
4. Front D., Israel O., Semin. Nucl. Med., 25, 60-71 (1995).
5. Hoffer P., J. Nucl. Med., 21, 484-488 (1980).
6. Lin W. Y., Lan J. L., Wang S. J., J. Nucl. Med., 39, 2137-2141 (1998).
7. Ito Y. O. S., Sato K., Takahashi K., Sato T., Kanno I., Radiology, 100, 357-362 (1971).
8. Lavender J. P., Lowe J., Barker J. R., Burn J. I., Chaudhri M. A., Br. J. Radiol., 44, 361-366 (1971).
9. Edwards C. L., Hayes R. L., J. Nucl. Med., 10, 103-105 (1969).
10. Abe S., Hasegawa S., Nirasawa M., Sato N., Ohkubo Y., Hepatol. Res., 25, 306-311 (2003).
11. Abe S., Suyama S., Shishido H., Sato M., Ohtake Y., Sato N., Ohkubo Y., Biol. Pharm. Bull., 27, 1913-1915 (2004).
12. Castillo T., Koop D. R., Kamimura S., Triadafilopoulos G., Tsukamoto H., Hepatology, 16, 992-996 (1992).
13. Castro J. A., "Mechanistic Studies and Prevention of Free Radical Cell Injury," MacMillan, London, 1984.
14. Mico B. A., Pohl L. R., Arch. Biochem. Biophys., 225, 596-609 (1983).
15. Forni L. G., Packer J. E., Slater T. F., Willson R. L., Chem. Biol. Interact., 45, 171-177 (1983).
16. Cheeseman K. H., Albano E. F., Tomasi A., Slater T. F., Environ. Health Perspect., 64, 85-101 (1985).
17. Comporti M., Lab. Invest., 53, 599-623 (1985).
18. Tribble D. L., Aw T. Y., Jones D. P., Hepatology, 7, 377-386 (1987).
19. Haouzi D., Lekehal M., Moreau A., Moulis C., Feldmann G., Robin M. A., Letteron P., Fau D., Pessayre D., Hepatology, 32, 303-311 (2000).
20. Jaeschke H., Smith C. W., Clemens M. G., Ganey P. E., Roth R. A., Toxicol. Appl. Pharmacol., 139, 213-226 (1996).
21. Nicotera P., Bellomo G., Orrenius S., Annu. Rev. Pharmacol. Toxicol., 32, 449-470 (1992).
22. Baron J., Redick J. A., Guengerich F. P., J. Biol. Chem., 256, 5931-5937 (1981).
23. Baron J., Redick J. A., Guengerich F. P., J. Biol. Chem., 257, 953-957 (1982).
24. Gooding P. E., Chayen J., Sawyer B., Slater T. F., Chem. Biol. Interact., 20, 299-310 (1978).
25. Buhler R., Lindros K. O., Nordling A., Johansson I., Ingelman-Sundberg M., Eur. J. Biochem., 204, 407-412 (1992).
26. Gumucio J., Chinanale J., "Liver Cell Heterogeneity," Raven Press, New York, 1988.
27. Baron J., Kawabata T., Knapp S., Voight J., Redick J. A., Jakoby W. B., Guengerich F. P., "Intrahepatic Distribution of Xenobiotic-Metabolizing Enzymes," Taylor and Francis, New York, 1984.
28. Thurman R. G., Kauffman F. C., Baron J., "Biotransformation and Zonal Toxicity," Plenum Press, New York, 1986.
29. Ohtake Y., Maruko A., Kojima S., Ono T., Nagashima T., Fukumoto M., Suyama S., Abe S., Sato N., Ohkubo Y., Biol. Pharm. Bull., 27, 1758-1762 (2004).
30. Lindros K. O., Penttila K. E., Biochem. J., 228, 757-760 (1985).
31. Gebhardt R., Cancer Res., 50, 4407-4410 (1990).
32. Yuasa S., Sudoh A., Nakao Y., Umezu K., Jpn. J. Pharmacol., 41, 205-210 (1986).
33. Schanne F. A., Kane A. B., Young E. E., Farber J. L., Science, 206, 700-702 (1979).
34. Oinonen T., Lindros K. O., Biochem. J., 329, 17-35 (1998).
35. Kohno H., Hoshino Y., Katoh S., Ohkubo Y., Experientia, 48, 386-388 (1992).